Erik Hooijberg

4.8k citations

95 papers · 3.2k indexed · h-index 34

Immunology top 1%
Oncology top 2%
Molecular Biology top 10%
Genetics top 5%
Epidemiology top 10%

Co-authors: Janneke J. Ruizendaal Chris J.L.M. Meijer Tanja D. de Gruijl Hergen Spits Esther W. M. Kueter Hetty J. Bontkes Rik J. Scheper Duco Kramer
Topics: Immunotherapy and Immune Responses (55 papers)CAR-T cell therapy research (35 papers)Immune Cell Function and Interaction (26 papers)
Cited by: Immunology Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nature Communications The Journal of Experimental Medicine
Partner nations: Netherlands United States Germany

In The Last Decade

Erik Hooijberg

95 papers receiving 3.2k citations

Peers

Countries citing papers authored by Erik Hooijberg

Since Specialization

Citations

This map shows the geographic impact of Erik Hooijberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Hooijberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Hooijberg more than expected).

Fields of papers citing papers by Erik Hooijberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Hooijberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Hooijberg. The network helps show where Erik Hooijberg may publish in the future.

Co-authorship network of co-authors of Erik Hooijberg

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Hooijberg. A scholar is included among the top collaborators of Erik Hooijberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Hooijberg. Erik Hooijberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma 2024 ·JCI Insight ·Joris L. Vos,Joleen J.H. Traets,Xiaohang Qiao,Iris M. Seignette,Dennis Peters,Michel W.J.M. Wouters,Erik Hooijberg,Annegien Broeks,Jacqueline E. van der Wal,Barış Karakullukçu,W. Martin C. Klop,Arash Navran,Marc van Beurden,Oscar R. Brouwer,Luc G.T. Morris,Mariëtte I.E. van Poelgeest,Ellen Kapiteijn,John B.A.G. Haanen,Christian U. Blank,Charlotte L. Zuur	5
2	Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors 2024 ·Nature Communications ·Alberto Gil-Jimenez,Nick van Dijk,Joris L. Vos,Yoni Lubeck,Maurits L. van Montfoort,Dennis Peters,Erik Hooijberg,Annegien Broeks,Charlotte L. Zuur,Bas W.G. van Rhijn,Daniël J. Vis,Michiel S. van der Heijden,Lodewyk F.A. Wessels	10
3	Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment 2024 ·Clinical Cancer Research ·(unknown),(unknown),Sandra van Wilpe,Iris M. Seignette,(unknown),(unknown),Alberto Gil-Jimenez,Dennis Peters,Wim Brugman,(unknown),Erik Hooijberg,Annegien Broeks,Bas W.G. van Rhijn,Laura S. Mertens,Antoine G. van der Heijden,Niven Mehra,Maurits L. van Montfoort,Lodewyk F.A. Wessels,Daniël J. Vis,Michiel S. van der Heijden	3
4	Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ 2021 ·npj Breast Cancer ·Mathilde M. Almekinders,Michael Schaapveld,Bram Thijssen,Lindy L. Visser,Tycho Bismeijer,Joyce Sanders,Edoardo Isnaldi,Ingrid Hofland,Marjolijn Mertz,Lodewyk F.A. Wessels,Annegien Broeks,Erik Hooijberg,Wilbert Zwart,Esther H. Lips,Christine Desmedt,Jelle Wesseling	15
5	Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy 2020 ·European Journal of Cancer ·(unknown),Ashley Cimino‐Mathews,Yoni Lubeck,(unknown),Mark Opdam,Joyce Sanders,Erik Hooijberg,Annelot van Rossum,Zuzana Loncová,Dietmar Rieder,Zlatko Trajanoski,Marieke A. Vollebergh,Marcelo Sobral‐Leite,Koen Van de Vijver,Annegien Broeks,(unknown),Harm van Tinteren,Sabine C. Linn,Hugo M. Horlings,Marleen Kok	18
6	Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial 2019 ·Cancer Immunology Immunotherapy ·Bas D. Koster,Saskia J. Santegoets,(unknown),Arnold Baars,S. Marieke van Ham,Rik J. Scheper,Erik Hooijberg,Tanja D. de Gruijl,Alfons J.M. van den Eertwegh	19
7	Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines 2014 ·Cancer Immunology Immunotherapy ·Jurjen M. Ruben,Willemijn van den Ancker,Hetty J. Bontkes,Theresia M. Westers,Erik Hooijberg,Gert J. Ossenkoppele,Tanja D. de Gruijl,Arjan A. van de Loosdrecht	31
8	Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients 2013 ·Journal of Translational Medicine ·Annelies W. Turksma,Hetty J. Bontkes,Janneke J. Ruizendaal,Kirsten Scholten,(unknown),(unknown),(unknown),Saskia A.G.M. Cillessen,Saskia J. Santegoets,Tanja D. de Gruijl,C. René Leemans,Chris J.L.M. Meijer,Erik Hooijberg	9
9	IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells 2013 ·Journal of Translational Medicine ·Saskia J. Santegoets,Annelies W. Turksma,Megan M. Suhoski,Anita G.M. Stam,Steve Albelda,Erik Hooijberg,Rik J. Scheper,Alfons JM van den Eertwegh,Winald R. Gerritsen,Daniel J. Powell,Carl H. June,Tanja D. de Gruijl	75
10	Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer 2011 ·Clinical Cancer Research ·Vincent A. de Weger,Annelies W. Turksma,Quirinus J.M. Voorham,Zelda Euler,Herman Bril,Alfons J. van den Eertwegh,Elisabeth Bloemena,Herbert M. Pinedo,Jan B. Vermorken,Harm van Tinteren,Gerrit A. Meijer,Erik Hooijberg	54
11	Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer 2011 ·Journal of Translational Medicine ·Kirsten Scholten,Annelies W. Turksma,Janneke J. Ruizendaal,Muriel van den Hende,Sjoerd H. van der Burg,Mirjam H.M. Heemskerk,Chris J.L.M. Meijer,Erik Hooijberg	21
12	High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model 2011 ·Cancer Immunology Immunotherapy ·Rieneke van de Ven,Sue Ellen Verbrugge,Anneke W. Reurs,Hetty J. Bontkes,Erik Hooijberg,Gerrit Jansen,Rik J. Scheper,George L. Scheffer,Tanja D. de Gruijl	6
13	IFN-γ-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses 2008 ·The Journal of Immunology ·Marı́a Moreno,Johan W. Molling,Silvia von Mensdorff‐Pouilly,René H.M. Verheijen,Erik Hooijberg,Duco Kramer,Anneke W. Reurs,Alfons J.M. van den Eertwegh,B. Mary E. von Blomberg,Rik J. Scheper,Hetty J. Bontkes	46
14	Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells 2008 ·Clinical Immunology ·Hetty J. Bontkes,Duco Kramer,Janneke J. Ruizendaal,Chris J.L.M. Meijer,Erik Hooijberg	46
15	Identification of a potential human telomerase reverse transcriptase–derived, HLA-A1–restricted cytotoxic T-lymphocyte epitope 2005 ·Cancer Immunology Immunotherapy ·Marco W.J. Schreurs,Esther W. M. Kueter,Kirsten Scholten,Duco Kramer,Chris J.L.M. Meijer,Erik Hooijberg	16
16	In vitro priming of tumor-specific cytotoxic T lymphocytes from healthy donors using allogeneic dendritic cells derived from the MUTZ-3 cell line (NMDC) 2004 ·Cancer Research ·Saskia J. Santegoets,Marco W.J. Schreurs,Allan J. Masterson,Hans Baumeister,Steffen Goletz,Esther W. M. Kueter,Sinéad M. Lougheed,(unknown),Rik J. Scheper,Erik Hooijberg,Tanja D. de Gruijl	1
17	In Vitro Generation and Life Span Extension of Human Papillomavirus Type 16-Specific, Healthy Donor-Derived CTL Clones 2003 ·The Journal of Immunology ·Marco W.J. Schreurs,Kirsten Scholten,Esther W. M. Kueter,Janneke J. Ruizendaal,Chris J.L.M. Meijer,Erik Hooijberg	51
18	Signal-Regulatory Protein α-CD47 Interactions Are Required for the Transmigration of Monocytes Across Cerebral Endothelium 2002 ·The Journal of Immunology ·Helga E. de Vries,Jerome J. A. Hendriks,Henk Honing,Chantal Renardel de Lavalette,Susanne M. A. van der Pol,Erik Hooijberg,Christine D. Dijkstra,Timo K. van den Berg	112
19	Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer 2002 ·Gastroenterology ·Catherine van Montfrans,Erik Hooijberg,(unknown),Esther C. de Jong,Hergen Spits,Anje A. te Velde,Sander J. H. van Deventer	35
20	Immortalization of Human CD8+ T Cell Clones by Ectopic Expression of Telomerase Reverse Transcriptase 2000 ·The Journal of Immunology ·Erik Hooijberg,Janneke J. Ruizendaal,Peter J.F. Snijders,Esther W. M. Kueter,Jan M.M. Walboomers,Hergen Spits	144

About Erik Hooijberg

Erik Hooijberg is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (55 papers), CAR-T cell therapy research (35 papers) and Immune Cell Function and Interaction (26 papers). The work is most often cited by research in Immunology (2.0k citations), Oncology (1.4k citations) and Molecular Biology (1.1k citations). Erik Hooijberg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Janneke J. Ruizendaal, Chris J.L.M. Meijer, Tanja D. de Gruijl, Hergen Spits, Esther W. M. Kueter, Hetty J. Bontkes, Rik J. Scheper, Duco Kramer, Saskia J. Santegoets and Nuno Clode. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact